Computational intelligence oncology applications (6 Ergebnisse)

Titel
Mit der Detailsuche verfeinern

Optimieren Sie Ihre Suche

  • Bücher (6)

  • Neu (6)

bis

Benutzerdefinierte Preisspanne (EUR)

bis

    • Sprache: Englisch

      Verlag: Springer, 2023

      9811692238 / 9789811692239

      Serie: Buch 507 von 538 - Studies in Computational Intelligence

      • Softcover

      Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes KönigreichRia Christie Collections

      Verkäufer/-in mit 5 Sternen
      Verkäufer/-in kontaktieren

      Zustand: Neu

      EUR 190,16

      EUR 13,17 Versand 
      Versand von Vereinigtes Königreich nach USA

      Anzahl: Mehr als 20 verfügbar

      Zustand: New. In.

    • Sprache: Englisch

      Verlag: Springer, 2022

      9811692203 / 9789811692208

      Serie: Buch 507 von 538 - Studies in Computational Intelligence

      • Hardcover

      Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes KönigreichRia Christie Collections

      Verkäufer/-in mit 5 Sternen
      Verkäufer/-in kontaktieren

      Zustand: Neu

      EUR 190,16

      EUR 13,17 Versand 
      Versand von Vereinigtes Königreich nach USA

      Anzahl: Mehr als 20 verfügbar

      Zustand: New. In.

    • Weitere Bilder

      Sprache: Englisch

      Verlag: Springer, 2023

      9811692238 / 9789811692239

      Serie: Buch 507 von 538 - Studies in Computational Intelligence

      • Softcover

      Anbieter: preigu, Osnabrück, Deutschlandpreigu

      Verkäufer/-in mit 5 Sternen
      Verkäufer/-in kontaktieren

      Zustand: Neu

      EUR 158,05

      EUR 70,00 Versand 
      Versand von Deutschland nach USA

      Anzahl: 5 verfügbar

      Taschenbuch. Zustand: Neu. Computational Intelligence in Oncology | Applications in Diagnosis, Prognosis and Therapeutics of Cancers | Khalid Raza | Taschenbuch | xx | Englisch | 2023 | Springer | EAN 9789811692239 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

    • Sprache: Englisch

      Verlag: Springer Nature, 2023

      9811692238 / 9789811692239

      Serie: Buch 507 von 538 - Studies in Computational Intelligence

      • Softcover

      Anbieter: Revaluation Books, Exeter, Vereinigtes KönigreichRevaluation Books

      Verkäufer/-in mit 5 Sternen
      Verkäufer/-in kontaktieren

      Zustand: Neu

      EUR 276,31

      EUR 14,58 Versand 
      Versand von Vereinigtes Königreich nach USA

      Anzahl: 2 verfügbar

      Paperback. Zustand: Brand New. 487 pages. 9.25x6.10x0.98 inches. In Stock.

    • Sprache: Englisch

      Verlag: Springer, 2023

      9811692238 / 9789811692239

      Serie: Buch 507 von 538 - Studies in Computational Intelligence

      • Softcover

      Anbieter: AHA-BUCH GmbH, Einbeck, DeutschlandAHA-BUCH GmbH

      Verkäufer/-in mit 5 Sternen
      Verkäufer/-in kontaktieren

      Zustand: Neu

      EUR 253,89

      EUR 30,50 Versand 
      Versand von Deutschland nach USA

      Anzahl: 1 verfügbar

      Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book encapsulates recent applications of CI methods in the field of computational oncology, especially cancer diagnosis, prognosis, and its optimized therapeutics.The cancer has been known as a heterogeneous disease categorized in several different subtypes. According to WHO's recent report, cancer is a leading cause of death worldwide, accounting for over 10 million deaths in the year 2020. Therefore, its early diagnosis, prognosis, and classification to a subtype have become necessary as it facilitates the subsequent clinical management and therapeutics plan. Computational intelligence (CI) methods, including artificial neural networks (ANNs), fuzzy logic, evolutionary computations, various machine learning and deep learning, and nature-inspired algorithms, have been widely utilized in various aspects of oncology research, viz. diagnosis, prognosis, therapeutics, and optimized clinical management.Appreciable progress has been made toward the understanding the hallmarks of cancer development, progression, and its effective therapeutics. However, notwithstanding the extrinsic and intrinsic factors which lead to drastic increment in incidence cases, the detection, diagnosis, prognosis, and therapeutics remain an apex challenge for the medical fraternity. With the advent in CI-based approaches, including nature-inspired techniques, and availability of clinical data from various high-throughput experiments, medical consultants, researchers, and oncologists have seen a hope to devise and employ CI in various aspects of oncology. The main aim of the book is to occupy state-of-the-art applications of CI methods which have been derived from core computer sciences to back medical oncology. This edited book covers artificial neural networks, fuzzy logic and fuzzy inference systems, evolutionary algorithms, various nature-inspired algorithms, and hybrid intelligent systems which are widely appreciated for the diagnosis, prognosis, and optimization of therapeutics of various cancers. Besides, this book also covers multi-omics exploration, gene expression analysis, gene signature identification of cancers, genomic characterization of tumors, anti-cancer drug design and discovery, drug response prediction by means of CI, and applications of IoT, IoMT, and blockchain technology in cancer research.

    • Sprache: Englisch

      Verlag: Springer, 2022

      9811692203 / 9789811692208

      Serie: Buch 507 von 538 - Studies in Computational Intelligence

      • Hardcover

      Anbieter: AHA-BUCH GmbH, Einbeck, DeutschlandAHA-BUCH GmbH

      Verkäufer/-in mit 5 Sternen
      Verkäufer/-in kontaktieren

      Zustand: Neu

      EUR 253,89

      EUR 30,50 Versand 
      Versand von Deutschland nach USA

      Anzahl: 1 verfügbar

      Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book encapsulates recent applications of CI methods in the field of computational oncology, especially cancer diagnosis, prognosis, and its optimized therapeutics.The cancer has been known as a heterogeneous disease categorized in several different subtypes. According to WHO's recent report, cancer is a leading cause of death worldwide, accounting for over 10 million deaths in the year 2020. Therefore, its early diagnosis, prognosis, and classification to a subtype have become necessary as it facilitates the subsequent clinical management and therapeutics plan. Computational intelligence (CI) methods, including artificial neural networks (ANNs), fuzzy logic, evolutionary computations, various machine learning and deep learning, and nature-inspired algorithms, have been widely utilized in various aspects of oncology research, viz. diagnosis, prognosis, therapeutics, and optimized clinical management.Appreciable progress has been made toward the understanding the hallmarks of cancer development, progression, and its effective therapeutics. However, notwithstanding the extrinsic and intrinsic factors which lead to drastic increment in incidence cases, the detection, diagnosis, prognosis, and therapeutics remain an apex challenge for the medical fraternity. With the advent in CI-based approaches, including nature-inspired techniques, and availability of clinical data from various high-throughput experiments, medical consultants, researchers, and oncologists have seen a hope to devise and employ CI in various aspects of oncology. The main aim of the book is to occupy state-of-the-art applications of CI methods which have been derived from core computer sciences to back medical oncology. This edited book covers artificial neural networks, fuzzy logic and fuzzy inference systems, evolutionary algorithms, various nature-inspired algorithms, and hybrid intelligent systems which are widely appreciated for the diagnosis, prognosis, and optimization of therapeutics of various cancers. Besides, this book also covers multi-omics exploration, gene expression analysis, gene signature identification of cancers, genomic characterization of tumors, anti-cancer drug design and discovery, drug response prediction by means of CI, and applications of IoT, IoMT, and blockchain technology in cancer research.